Literature DB >> 9554430

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

K O Lim1, E Adalsteinsson, D Spielman, E V Sullivan, M J Rosenbloom, A Pfefferbaum.   

Abstract

OBJECTIVE: To apply in vivo proton magnetic resonance spectroscopy imaging estimates of N-acetylaspartate (NAA), a neuronal marker, to clarify the relative contribution of neuronal and glial changes to the widespread volume deficit of cortical gray matter seen in patients with schizophrenia with magnetic resonance images.
METHODS: Ten male veterans meeting criteria of the DSM-IV, for schizophrenia and 9 healthy age-matched men for comparison were scanned using spectroscopic, anatomical, and field-map sequences. Instrument and collection variables were standardized to allow an estimation of comparable values for NAA, choline, and creatine for all subjects. Metabolite values from each voxel on 3 upper cortical slices were regressed against the gray tissue proportion of that voxel to derive estimates of gray and white matter NAA, creatine, and choline concentrations.
RESULTS: The volume of cortical gray matter was reduced in patients with schizophrenia, but NAA signal intensity from a comparable region was normal. In contrast, the volume of cortical white matter was normal in patients with schizophrenia, but NAA signal intensity from a comparable region was reduced.
CONCLUSIONS: The lack of reduction in gray matter NAA signal intensity suggests that the cortical gray matter deficit in these patients involved both neuronal and glial compartments rather than a neurodegenerative process in which there is a decrease in the neuronal relative to the glial compartment. Reduced white matter NAA signal intensity without a white matter volume deficit may reflect abnormal axonal connections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554430     DOI: 10.1001/archpsyc.55.4.346

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  25 in total

Review 1.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology.

Authors:  Thomas J Whitford; Christopher J Rennie; Stuart M Grieve; C Richard Clark; Evian Gordon; Leanne M Williams
Journal:  Hum Brain Mapp       Date:  2007-03       Impact factor: 5.038

3.  Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.

Authors:  Robert E McCullumsmith; Daya Gupta; Monica Beneyto; Emily Kreger; Vahram Haroutunian; Kenneth L Davis; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2007-01-12       Impact factor: 4.939

4.  Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).

Authors:  Rei Yasukawa; Tsuyoshi Miyaoka; Shoichi Mizuno; Takuji Inagaki; Jun Horiguchi; Kazushige Oda; Hajime Kitagaki
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

5.  Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

Authors:  Juan R Bustillo; Hongji Chen; Charles Gasparovic; Paul Mullins; Arvind Caprihan; Clifford Qualls; William Apfeldorf; John Lauriello; Stefan Posse
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

Review 6.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

7.  Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study.

Authors:  Tonya White; Vincent A Magnotta; H Jeremy Bockholt; Sumner Williams; Stuart Wallace; Stefan Ehrlich; Bryon A Mueller; Beng-Choon Ho; Rex E Jung; Vincent P Clark; John Lauriello; Juan R Bustillo; S Charles Schulz; Randy L Gollub; Nancy C Andreasen; Vince D Calhoun; Kelvin O Lim
Journal:  Schizophr Bull       Date:  2009-09-21       Impact factor: 9.306

8.  Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.

Authors:  Subroto Ghose; Jeremy M Crook; Cynthia L Bartus; Thomas G Sherman; Mary M Herman; Thomas M Hyde; Joel E Kleinman; Mayada Akil
Journal:  Int J Neurosci       Date:  2008-11       Impact factor: 2.292

9.  Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.

Authors:  Clare L Beasley; Andrew J Dwork; Gorazd Rosoklija; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasa Davceva; Andrew R Tait; Suzana K Straus; William G Honer
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

10.  Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

Authors:  John M Pearce; Richard A Komoroski; Robert E Mrak
Journal:  Magn Reson Med       Date:  2009-01       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.